Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8314256 | 0.95 | SLC33A1 (0.46) | SLC33A1 | |
| SCHEMBL9256744 | 0.91 | SLC33A1 (0.38) | SLC33A1 | |
| SCHEMBL9253560 | 0.89 | SLC33A1 (0.36) | SLC33A1 | |
| SCHEMBL9256922 | 0.87 | SLC33A1 (0.43) | SLC33A1AGTR1 | |
| SCHEMBL9256561 | 0.87 | SLC33A1 (0.37) | SLC33A1 | |
| SCHEMBL9255130 | 0.86 | USP2 (0.39) | SLC33A1 | |
| SCHEMBL9254444 | 0.85 | SLC33A1 (0.48) | SLC33A1 | |
| SCHEMBL9251346 | 0.85 | SLC33A1 (0.37) | SLC33A1 | |
| SCHEMBL9253961 | 0.84 | SLC33A1 (0.46) | SLC33A1 | |
| SCHEMBL9257779 | 0.84 | SLC33A1 (0.46) | SLC33A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6218414-B1 | ADMINISTERING AN EFFECTIVE AMOUNT OF AN ANGIOTENSIN II ANTAGONIST AND A BENZOFURAN DERIVATIVE WITH ANTIARRHYTHMIC ACTIVITY FOR THERAPY OF CARDIOVASCULAR COMPLAINTS | SANOFI (FR) | 2001-04-17 | — | — | US | disclosed |
| EP-0752249-A2 | Use of an angiotensin II antagonist and a benzofurane derivative having antiarithmic activity for the manufacture of a medicament for the treatment of cardiovascular disorders | SANOFI (FR) | 1997-01-08 | — | — | EP | disclosed |
| US-5387747-A | Used in the treatment and prevention of cardiovascular diseases: hypertension, cardiac insufficiency and atherosclerosis | LABORATOIRES UPSA (FR) | 1995-02-07 | — | — | US | disclosed |